This page shows information from a previous legislative session and is presented for archive purposes only.

SB149 - TO REGULATE THE SUBSTITUTION OF BIOSIMILAR BIOLOGICAL PRODUCTS FOR CERTAIN PRESCRIBED PRODUCTS.


Bill Number:
SB149 PDF
SB149
Status:
Senate -- Sine Die adjournment
Originating Chamber:
Senate
Lead Sponsor:
Files
Introduction Date:
1/28/2013 2:22:00 PM

Upcoming Events

No upcoming events for this bill.

Bill Status History

Chamber
Date
Action
Vote
Senate
5/17/2013 2:48:01 PM
Sine Die adjournment
Senate
5/17/2013 2:47:58 PM
Died in Senate at Sine Die adjournment.
Senate
3/20/2013 2:18:25 PM
Recommended for study in the Interim Committee on Senate Committee on Public Health, Welfare and Labor
Senate
3/20/2013 2:17:38 PM
Withdrawn from Committee and placed on calendar.
Senate
2/4/2013 1:37:32 PM
Re-referred to Senate Committee on Public Health, Welfare and Labor
Senate
2/4/2013 1:37:10 PM
REPORTED CORRECTLY ENGROSSED
Senate
2/4/2013 11:58:21 AM
Amendment # 1 read the first time, rules suspended, read the second time and adopted, ordered engrossed.
Senate
2/4/2013 11:57:56 AM
Withdrawn from Committee for purpose of amendment # 1
Senate
1/28/2013 2:24:25 PM
Read first time, rules suspended, read second time, referred to Senate Committee on Public Health, Welfare and Labor
Senate
1/28/2013 2:22:00 PM
Filed

Amendments

Chamber
No.
Sponsor
Introduction Date
Document
Chamber: Senate
Amendment Number: S1
Files
1/31/2013 10:54:00 AM
SB149-S1 PDF
View Previous Versions

DFA Fiscal Impacts

FI Number
Requestor
Date Issued
Document
DFA1
1/29/2013
=SB149-DFA1 PDF
DFA2
2/4/2013
=SB149-DFA2 PDF